alfuzosin
Selected indexed studies
- Alfuzosin. (, 2012) [PMID:31644057]
- Alfuzosin and Its Effect on Ejaculatory Dysfunction: A Systematic Review. (World J Mens Health, 2021) [PMID:32009306]
- Alfuzosin: a clinically uroselective alpha1-blocker. (World J Urol, 2002) [PMID:12022709]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Alfuzosin. (2012) pubmed
- Alfuzosin and Its Effect on Ejaculatory Dysfunction: A Systematic Review. (2021) pubmed
- Alfuzosin: a clinically uroselective alpha1-blocker. (2002) pubmed
- Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis. (2021) pubmed
- Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience. (2006) pubmed
- Alfuzosin for the management of benign prostate hyperplasia. (2003) pubmed
- Alfuzosin-induced hepatotoxicity. (2000) pubmed
- Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker. (2001) pubmed
- Alfuzosin-associated dermatomyositis. (1998) pubmed
- Alfuzosin hydrochloride for the treatment of benign prostatic hyperplasia. (2003) pubmed